The way that WES is behaving doesn't make sense.
I assume they have identified Pharmacy as a strategic segment to be in.
Once they have done that, to try to penny-pinch makes no sense, especially when API is so small compared to them (1% of their market cap)
- Forums
- ASX - By Stock
- API
- Ann: API Board rejects indicative proposal from Wesfarmers
Ann: API Board rejects indicative proposal from Wesfarmers, page-18
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online